Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4

被引:124
|
作者
Komurasaki, T
Toyoda, H
Uchida, D
Morimoto, S
机构
[1] Molecular Biology Laboratory, Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd., Ohmiyashi, Saitama 330, I-403, Yoshino-cho
关键词
epiregulin; EGF family; ErbB receptors; tyrosine phosphorylation;
D O I
10.1038/sj.onc.1201458
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epiregulin is a member of the epidermal growth factor (EGF) family, and has certain characteristics that are different from that of EGF, including mitogenic responses and binding to EGF receptor (EGFR). Epiregulin may also have another cell surface receptor and/or induces different receptor heterodimerizations for intracellular signaling. We investigated the binding ability of epiregulin to four ErbB family receptors using four human breast carcinoma cell lines that expressed different subsets of receptors. Chemical cross-linking experiments showed that [I-125]epiregulin directly bound to each of EGFR and ErbB-4 but not to ErbB-2 and ErbB-3. Furthermore, although epiregulin stimulated tyrosine phosphorylation of all four ErbB receptors, the main intracellular signal was mediated by ErbB-4 and/or EGFR. The pattern of activation of ErbB family receptors was different from that of other EGF-related ligands. Our findings indicate that ErbB-4 and EGFR are receptors for epiregulin, and suggest that EGF-related ligands transduce signals for different biological responses by the hierarchical mechanism.
引用
收藏
页码:2841 / 2848
页数:8
相关论文
共 50 条
  • [21] Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes
    Altenschmidt, U
    Kahl, R
    Moritz, D
    Schnierle, BS
    Gerstmayer, B
    Wels, W
    Groner, B
    CLINICAL CANCER RESEARCH, 1996, 2 (06) : 1001 - 1008
  • [22] Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancer
    Gilmour, LMR
    Macleod, KG
    McCaig, A
    Gullick, WJ
    Smyth, JF
    Langdon, SP
    CANCER RESEARCH, 2001, 61 (05) : 2169 - 2176
  • [23] Role of the N-terminus of epidermal growth factor in ErbB-2/ErbB-3 binding studied by phage display
    Stortelers, C
    Souriau, C
    van Liempt, E
    van de Poll, MLM
    van Zoelen, EJJ
    BIOCHEMISTRY, 2002, 41 (27) : 8732 - 8741
  • [24] Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2
    Riese, DJ
    Komurasaki, T
    Plowman, GD
    Stern, DF
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (18) : 11288 - 11294
  • [25] The ERBB-4 receptor involvement in brain injury
    Erlich, S
    Lupowitz, Z
    Shohami, E
    Pinkas-Kramarski, R
    NEUROSCIENCE LETTERS, 1999, : S15 - S15
  • [26] Expression of keratinocyte growth factor receptor compared with that of epidermal growth factor receptor and erbB-2 in endometrial adenocarcinoma
    Visco, V
    Carico, E
    Marchese, C
    Torrisi, MR
    Frati, L
    Vecchione, A
    Muraro, R
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (03) : 431 - 435
  • [27] Desensitization by Different Strategies of Epidermal Growth Factor Receptor and ErbB4
    Yamamoto, Hideyuki
    Higa-Nakamine, Sayomi
    Noguchi, Nobuhiro
    Maeda, Noriko
    Kondo, Yutaka
    Toku, Seikichi
    Kukita, Ichiro
    Sugahara, Kazuhiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2014, 124 (03) : 287 - 293
  • [28] Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2, and ErbB3, in human ocular surface epithelia
    Liu, ZG
    Carvajal, M
    Carraway, CAC
    Carraway, K
    Pflugfelder, SC
    CORNEA, 2001, 20 (01) : 81 - 85
  • [29] Structural aspects of the epidermal growth factor receptor required for transmodulation of erbB-2/neu
    Worthylake, R
    Wiley, HS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (13) : 8594 - 8601
  • [30] EXPRESSION AND ACTIVATION OF ERBB-2 AND EPIDERMAL GROWTH-FACTOR RECEPTOR IN LUNG ADENOCARCINOMAS
    RACHWAL, WJ
    BONGIORNO, PF
    ORRINGER, MB
    WHYTE, RI
    ETHIER, SP
    BEER, DG
    BRITISH JOURNAL OF CANCER, 1995, 72 (01) : 56 - 64